Exact Sciences (EXAS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5%. A quarter ago, it was expected that this molecular diagnostics company would post a loss of $0.37 per share when it actually produced a loss of $0.09, delivering a surprise of 75.68%.Over the last four quarters, ...